หน้าแรก
ค้นหา
Dr. Fred Saad - Professor and Chief of Urology
Dr Saad speaks about non muscular invasive Bladder Cancer
แสดงข้อมูลเพิ่มเติม 1
Dr. Fred Saad - Professor and Chief of Urology
Fred Saad, MD, highlights phase 1 study of 225Ac-PSMA-Trillium in mCRPC
Prostate Cancer What's new and What's coming
Dr. Saad on Radium-223 for Prostate Cancer
Exclusive interview on ARANOTE study: PSA response with darolutamide plus ADT in patients with mHSPC
Fred Saad, MD, shares the design and outcomes of the SPARTAN study in patients with nmCRPC
Fred Saad, MD, on darolutamide outcomes across comorbidity burdens
Fred Saad MD, on SPARTAN study highlights for oncologists that do not specialize in prostate cancer
Dr. Saad on Expanded Access Program With Radium-223
Fred Saad, MD, on genetic testing to be conducted in a patient with metastatic prostate cancer
Fred Saad, MD, shares impressions of the CARD study investigating cabazitaxel in nmCRPC patients
Fred Saad, MD, details safety concerns when presenting apalutamide + ADT to nmCRPC patients
Dr. Saad on Patients With mCRPC Eligible for 6-Doses of Radium-223
Options for Metastatic Castrate-Resistant Prostate Cancer
Dr Saad on the Safety Profile of Darolutamide Plus ADT in mHSPC
Paul F. Schellhammer Lecture in Urologic Oncology part 1 of 3
Réseau canadien IRTF de biomarqueurs du cancer de la prostate, le 25 juillet, 2012 -- Dr Fred Saad
2013-Cancer de la prostate - Une affaire d'hommes et de femmes
Le Golf contre le Cancer et la recherche sur le cancer de la prostate
Dr. Agarwal on Drug Development in Metastatic Castration-Sensitive Prostate Cancer
